Alzheimer's disease:  
CURRENT FOOD AND DRUG MEDICATIONS 

( There are only 5 medications approved by the Food and Drug Administration to treat AD. )

Please Help Support Alzheimer's Research Today! 
Your Alzheimer's donation will help billions live without it.
DONATE NOW

The transition from either epidemiological observation or the bench to rigorously tested clinical trials in patients with Alzheimer's disease is crucial in understanding which treatments are beneficial to patients. 

There are only 5 medications approved by the Food and Drug Administration to treat AD. Four of them are acetyl cholinesterase inhibitors (donepezil, galantamine, rivastigmine, and tacrine), and the fifth is the N-methyl-d-aspartate antagonist memantine. These medications ameliorate the symptoms and can improve the functioning of patients with AD, but they are not curative, nor do they significantly change the course of the illness. The most widely studied treatments aim to address the neuropathological findings over the last century and focus on acetylcholine, inflammatory markers, amyloid plaques, and tau-based neurofibrillary tangles. In this article, authors discuss some of the drugs that target these and other novel mechanisms and the rationale for some of the most promising new agents, and review recent findings, both positive and negative, in the treatment and prevention of AD. To get more: http://www3.interscience.wiley.com

TODAY'S PHOTO

The cardiovascular benefits of the dairy peptides

A combination of milk proteins may reduce hardening of the arteries, says a new study from Valio that support the cardiovascular benefits of the dairy peptides.   ... http://www.nutraingredients.com

Беларусь ТВ

Posted YVN (AMYLOID @ PHOTO)